Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Antimicrobial resistance stories

Sep 28, 2026

Merck discontinues Recarbrio antibiotic despite concerns over superbug resistance

Merck has discontinued Recarbrio, a crucial antibiotic used to treat drug-resistant infections, raising concerns among health experts about the availability of treatments for superbug resistance at a time when antimicrobial resistance remains a growing public health threat.

Sep 28, 2026·2 sources
00
Aug 6, 2026

Drug-Resistant Fungus Candida auris Spreads to 27 US States, Scientists Discover It Hides in Hair Follicles

Scientists have discovered how Candida auris, a deadly drug-resistant fungus that has infected over 3,000 patients across 27 US states this year, survives on human skin by hiding in hair follicles and hijacking the body's immune response. The pathogen, which the CDC considers an urgent antimicrobial threat, can colonize skin asymptomatically for months before becoming deadly if it enters the bloodstream through wounds or medical devices.

Aug 6, 2026·9 sources
00

Top claims

  • ▪The FDA bears primary responsibility for the commercial failure of Recarbrio
  • ▪Merck discontinued its antibiotic Recarbrio from the United States market in September 2026 without providing an explanation for the decision.
  • ▪The discontinuation of Recarbrio by Merck in September 2026 highlights ongoing concerns regarding the commitment of large pharmaceutical companies to the antibiotic field.

Subtopics

Infectious disease1Infectious Disease and Outbreaks1Pharmaceutical Industry1Public health1Public healthcare1

Related timelines

AI Data Center Gold Rush

104 stories

Congress

108 stories

Crypto hacks

100 stories

Strait of Hormuz blockage

148 stories

Trump administration

116 stories